Investor Overview
KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co...
Stock Information
NASDAQ CM$9.65NEWS
Kindred Biosciences to Announce First Quarter 2018 Financial Results
April 18, 2018
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
Kindred Biosciences to Present at the Oppenheimer 28th Annual Healthcare Conference
March 8, 2018
SAN FRANCISCO, March 8, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences Announces Fourth Quarter and Full Year 2017 Financial Results
March 1, 2018
SAN FRANCISCO, March 1, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...